And if you're thinking, well, surely this has never happened before, a viral hemorrhagic fever coming to the US via airline: Actually, it's happened seven times before.And no one caught Lassa from ...

About 100,000 to 300,000 cases of Lassa fever, and 5,000 deaths related to Lassa fever, occur in West Africa each year, according to the CDC. An anti-viral drug called ribavirin can treat Lassa ...

Since the beginning of winter, Xi'an, Northwest China's Shaanxi Province has recorded a series of hemorrhagic fever cases, a natural epidemic disease with a high fatality rate. Medical experts ...

A woman in England has been diagnosed with Crimean-Congo Hemorrhagic fever according to a new report from the U.K. Health Security Agency. The viral disease is spread by ticks and livestock ...

There is no specific treatment for Crimean-Congo hemorrhagic fever. Patients with the disease are given supportive care, such as fluids, electrolytes, oxygen and treatments to help with blood flow ...

Marburg hemorrhagic fever starts as a nonspecific febrile illness but rapidly progresses to include hemorrhagic complications and, in the most severe cases, a septic shock-like syndrome. Death is ...

Lassa fever is an acute viral hemorrhagic illness caused by Lassa virus. ... Patients with severe cases may develop facial swelling, fluid in the lung cavity, ...

Uganda confirms at least one case of Ebola hemorrhagic fever By . Reuters. Published Sep. 20, 2022, 4:30 a.m. ET. ... She said the patient with the confirmed case had high fever, ...

Liberia: In the shadow of a global pandemic that dominated health headlines for years, a persistent threat quietly continues to challenge West Africa. Lassa fever, a viral hemorrhagic illnessfirst ...

Cases of highly fatal viral hemorrhagic fever on the rise By TAKAHIRO TAKENOUCHI/ Staff Writer. February 20 ... Japan saw a record 110 SFTS patients in 2021 followed by 118 in 2022.

Exploratory analyses indicated that patients under the age of 21 years had a lower case fatality rate than those over the age of 45 years (57% vs. 94%, P=0.03), and patients presenting with fewer ...